Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yunxia Sui

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 18, 2017
Single-cell heterogeneity in ductal carcinoma in situ of breastMichael J Gerdes, Yesim Gökmen-Polar, Yunxia Sui, et al.
ACS Applied Materials & Interfaces|September 24, 2016
Enhancing the Spin-Orbit Coupling in Fe<sub>3</sub>O<sub>4</sub> Epitaxial Thin Films by Interface EngineeringZhaocong Huang, Wenqing Liu, Jinjin Yue, et al.
Annals of the Rheumatic Diseases|July 5, 2022
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trialDésirée van der Heijde, Xenofon Baraliakos, Joachim Sieper, et al.
British Journal of Cancer|January 8, 2021
Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breastSunil S Badve, Sanghee Cho, Yesim Gökmen-Polar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 1, 2021
Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label ExtensionAtul Deodhar, Désirée van der Heijde, Joachim Sieper, et al.
RMD Open|July 27, 2022
Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extensionDésirée van der Heijde, Atul Deodhar, Walter P Maksymowych, et al.
Lancet (London, England)|November 17, 2019
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trialDésirée van der Heijde, In-Ho Song, Aileen L Pangan, et al.
JCI Insight|June 2, 2017
Optimized multiplex immunofluorescence single-cell analysis reveals tuft cell heterogeneityEliot T McKinley, Yunxia Sui, Yousef Al-Kofahi, et al.
Plos One|July 18, 2009
Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonistsSreenivasan Paruthiyil, Aleksandra Cvoro, Xiaoyue Zhao, et al.
Biology Open|June 22, 2013
Quantitative single cell analysis of cell population dynamics during submandibular salivary gland development and differentiationDeirdre A Nelson, Charles Manhardt, Vidya Kamath, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 18, 2017
Single-cell heterogeneity in ductal carcinoma in situ of breastMichael J Gerdes, Yesim Gökmen-Polar, Yunxia Sui, et al.
ACS Applied Materials & Interfaces|September 24, 2016
Enhancing the Spin-Orbit Coupling in Fe<sub>3</sub>O<sub>4</sub> Epitaxial Thin Films by Interface EngineeringZhaocong Huang, Wenqing Liu, Jinjin Yue, et al.
Annals of the Rheumatic Diseases|July 5, 2022
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trialDésirée van der Heijde, Xenofon Baraliakos, Joachim Sieper, et al.
British Journal of Cancer|January 8, 2021
Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breastSunil S Badve, Sanghee Cho, Yesim Gökmen-Polar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 1, 2021
Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label ExtensionAtul Deodhar, Désirée van der Heijde, Joachim Sieper, et al.
RMD Open|July 27, 2022
Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extensionDésirée van der Heijde, Atul Deodhar, Walter P Maksymowych, et al.
Lancet (London, England)|November 17, 2019
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trialDésirée van der Heijde, In-Ho Song, Aileen L Pangan, et al.
JCI Insight|June 2, 2017
Optimized multiplex immunofluorescence single-cell analysis reveals tuft cell heterogeneityEliot T McKinley, Yunxia Sui, Yousef Al-Kofahi, et al.
Plos One|July 18, 2009
Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonistsSreenivasan Paruthiyil, Aleksandra Cvoro, Xiaoyue Zhao, et al.
Biology Open|June 22, 2013
Quantitative single cell analysis of cell population dynamics during submandibular salivary gland development and differentiationDeirdre A Nelson, Charles Manhardt, Vidya Kamath, et al.
Pageof 5